Titration of signalling output: insights into clinical combinations of MEK and AKT inhibitors

BACKGROUND: We aimed to understand the relative contributions of inhibiting MEK and AKT on cell growth to guide combinations of these agents. MATERIALS AND METHODS: A panel of 20 cell lines was exposed to either the MEK inhibitor, PD0325901, or AKT inhibitor, AKT 1/2 inhibitor. p-ERK and p-S6 ELISAs...

Descripción completa

Detalles Bibliográficos
Autores principales: Stewart, A., Thavasu, P., de Bono, J. S., Banerji, U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478974/
https://www.ncbi.nlm.nih.gov/pubmed/25908604
http://dx.doi.org/10.1093/annonc/mdv188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478974/
https://www.ncbi.nlm.nih.gov/pubmed/25908604
http://dx.doi.org/10.1093/annonc/mdv188

Ejemplares similares